Entera Bio Ltd. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Entera Bio Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Entera Bio Ltd. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.17M, a 7.08% increase year-over-year.
  • Entera Bio Ltd. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.58M, a 18.1% increase year-over-year.
  • Entera Bio Ltd. annual Operating Income (Loss) for 2023 was -$8.89M, a 31.7% increase from 2022.
  • Entera Bio Ltd. annual Operating Income (Loss) for 2022 was -$13M, a 6.55% decline from 2021.
  • Entera Bio Ltd. annual Operating Income (Loss) for 2021 was -$12.2M, a 9.39% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$8.89M +$4.13M +31.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$13M -$800K -6.55% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 -$12.2M -$1.05M -9.39% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$11.2M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.